128 related articles for article (PubMed ID: 8262487)
1. Insulin-resistant syndromes in children.
Caprio S; Amiel SA; Merkel P; Tamborlane WV
Horm Res; 1993; 39 Suppl 3():112-4. PubMed ID: 8262487
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance: an early metabolic defect of Turner's syndrome.
Caprio S; Boulware S; Diamond M; Sherwin RS; Carpenter TO; Rubin K; Amiel S; Press M; Tamborlane WV
J Clin Endocrinol Metab; 1991 Apr; 72(4):832-6. PubMed ID: 2005209
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone and insulin interactions.
Caprio S; Boulware D; Tamborlane V
Horm Res; 1992; 38 Suppl 2():47-9. PubMed ID: 1292982
[TBL] [Abstract][Full Text] [Related]
4. Glucose turnover and insulin clearance after growth hormone treatment in girls with Turner's syndrome.
Monti LD; Brambilla P; Caumo A; Magni F; Omati S; Nizzoli G; di Natale B; Galli-Kienle M; Cobelli C; Chiumello G; Pozza G
Metabolism; 1997 Dec; 46(12):1482-8. PubMed ID: 9439548
[TBL] [Abstract][Full Text] [Related]
5. Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner's syndrome. The impact of sex hormone replacement.
Gravholt CH; Naeraa RW; Nyholm B; Gerdes LU; Christiansen E; Schmitz O; Christiansen JS
Diabetes Care; 1998 Jul; 21(7):1062-70. PubMed ID: 9653596
[TBL] [Abstract][Full Text] [Related]
6. Decreased sensitivity to insulin-like growth factor I in Turner's syndrome: a study of monocytes and T lymphocytes.
Hochberg Z; Aviram M; Rubin D; Pollack S
Eur J Clin Invest; 1997 Jul; 27(7):543-7. PubMed ID: 9263738
[TBL] [Abstract][Full Text] [Related]
7. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.
Gravholt CH; Naeraa RW; Fisker S; Christiansen JS
J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance in a patient with diabetes mellitus associated with Turner's syndrome.
Kumon Y; Hisatake K; Suehiro T; Sumiyoshi R; Hashimoto K
Intern Med; 1994 Sep; 33(9):560-3. PubMed ID: 8000110
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone treatment in Turner's syndrome: short and long-term effects on metabolic parameters.
Haeusler G; Frisch H
Clin Endocrinol (Oxf); 1992 Mar; 36(3):247-53. PubMed ID: 1563078
[TBL] [Abstract][Full Text] [Related]
10. Is obesity-related insulin status the cause of blunted growth hormone secretion in Turner's syndrome?
Vaccaro F; Cianfarani S; Pasquino AM; Boscherini B
Metabolism; 1995 Aug; 44(8):1033-7. PubMed ID: 7637644
[TBL] [Abstract][Full Text] [Related]
11. Turner's syndrome and hypogonadotrophic hypogonadism: thalassemia major and hemochromatosis.
Afonso Lopes L; Benador D; Wacker P; Wyss M; Sizonenko PC
J Pediatr Endocrinol Metab; 1995; 8(1):73-7. PubMed ID: 7584702
[TBL] [Abstract][Full Text] [Related]
12. Type 1 diabetes mellitus in a 3 1/2 year-old girl with Turner's syndrome.
Gonc EN; Ozon A; Alikasifoglu A; Kandemir N
J Pediatr Endocrinol Metab; 2002; 15(8):1203-6. PubMed ID: 12387520
[TBL] [Abstract][Full Text] [Related]
13. Effect of obesity on endogenous secretion of growth hormone in Turner's syndrome.
Lu PW; Cowell CT; Jimenez M; Simpson JM; Silink M
Arch Dis Child; 1991 Oct; 66(10):1184-90. PubMed ID: 1953000
[TBL] [Abstract][Full Text] [Related]
14. Turner's syndrome and carbohydrate metabolism. I. Impaired insulin secretion after tolbutamide and glucagon stimulation tests: evidence of insulin deficiency.
AvRuskin TW; Crigler JF; Soeldner JS
Am J Med Sci; 1979; 277(2):145-52. PubMed ID: 463942
[TBL] [Abstract][Full Text] [Related]
15. Adrenocorticotrophin stimulation and HLA polymorphisms suggest a high frequency of heterozygosity for steroid 21-hydroxylase deficiency in patients with Turner's syndrome and their families.
Larizza D; Cuccia M; Martinetti M; Maghnie M; Dondi E; Salvaneschi L; Severi F
Clin Endocrinol (Oxf); 1994 Jan; 40(1):39-45. PubMed ID: 8306479
[TBL] [Abstract][Full Text] [Related]
16. Insulin resistance of puberty: a defect restricted to peripheral glucose metabolism.
Amiel SA; Caprio S; Sherwin RS; Plewe G; Haymond MW; Tamborlane WV
J Clin Endocrinol Metab; 1991 Feb; 72(2):277-82. PubMed ID: 1991798
[TBL] [Abstract][Full Text] [Related]
17. Glucose metabolism, insulin sensitivity and β-cell function in type A insulin resistance syndrome around puberty: a 9-year follow-up.
Huang Z; Liu J; Ma L; Wan X; He X; Fang D; Liao Z; Li Y
Horm Metab Res; 2014 Jan; 46(1):65-72. PubMed ID: 24155250
[TBL] [Abstract][Full Text] [Related]
18. Insulin resistance is an intrinsic defect independent of fat mass in women with Turner's syndrome.
Salgin B; Amin R; Yuen K; Williams RM; Murgatroyd P; Dunger DB
Horm Res; 2006; 65(2):69-75. PubMed ID: 16407654
[TBL] [Abstract][Full Text] [Related]
19. Celiac disease and Turner's syndrome: patient report.
Arslan D; Kuyucu T; Kendirci M; Kurtoglu S
J Pediatr Endocrinol Metab; 2000; 13(9):1629-31. PubMed ID: 11154159
[TBL] [Abstract][Full Text] [Related]
20. Influence of spontaneous or induced puberty on the growth promoting effect of treatment with growth hormone in girls with Turner's syndrome.
Massa G; Maes M; Heinrichs C; Vandeweghe M; Craen M; Vanderschueren-Lodeweyckx M
Clin Endocrinol (Oxf); 1993 Mar; 38(3):253-60. PubMed ID: 8458097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
